Saburo Sone

10.0k total citations · 1 hit paper
259 papers, 8.2k citations indexed

About

Saburo Sone is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Saburo Sone has authored 259 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Molecular Biology, 95 papers in Oncology and 85 papers in Immunology. Recurrent topics in Saburo Sone's work include Immunotherapy and Immune Responses (41 papers), Peptidase Inhibition and Analysis (27 papers) and Lung Cancer Treatments and Mutations (27 papers). Saburo Sone is often cited by papers focused on Immunotherapy and Immune Responses (41 papers), Peptidase Inhibition and Analysis (27 papers) and Lung Cancer Treatments and Mutations (27 papers). Saburo Sone collaborates with scholars based in Japan, United States and United Kingdom. Saburo Sone's co-authors include Yasuhiko Nishioka, Seiji Yano, Hisanori Uehara, Takeshi Ogura, Soji Kakiuchi, Masaki Hanibuchi, Wei Wang, Isaiah J. Fidler, Kenji Tani and Yasukazu Ohmoto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Immunology.

In The Last Decade

Saburo Sone

255 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations

2008 513 citations Seiji Yano, Wei Wang et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Saburo Sone Japan	48	3.5k	2.8k	2.2k	2.2k	1.1k	259	8.2k
Yasuhiko Nishioka Japan	41	2.7k 0.8×	2.3k 0.8×	1.7k 0.8×	1.6k 0.7×	608 0.6×	239	6.4k
James W. Mier United States	40	3.3k 0.9×	2.8k 1.0×	2.7k 1.2×	1.8k 0.8×	1.4k 1.3×	122	8.3k
Paul Nathan United Kingdom	46	3.6k 1.0×	3.8k 1.4×	1.1k 0.5×	2.0k 0.9×	1.0k 1.0×	272	7.9k
Luigi Ruco Italy	40	3.6k 1.0×	3.0k 1.1×	2.7k 1.2×	696 0.3×	1.1k 1.1×	161	9.6k
Humphrey Gardner United States	50	4.5k 1.3×	2.7k 1.0×	1.1k 0.5×	1.2k 0.5×	1.5k 1.4×	102	9.0k
Lucia R. Languino United States	58	6.3k 1.8×	2.0k 0.7×	1.4k 0.7×	1.6k 0.7×	2.5k 2.3×	149	11.2k
Matthew L. Sherman United States	41	3.2k 0.9×	2.1k 0.8×	2.2k 1.0×	945 0.4×	671 0.6×	134	7.8k
You Lü China	41	2.6k 0.8×	2.9k 1.0×	760 0.3×	2.6k 1.2×	1.0k 1.0×	263	7.0k
James H. Resau United States	58	5.2k 1.5×	3.1k 1.1×	1.2k 0.5×	1.4k 0.6×	1.6k 1.5×	186	10.7k
Yusuke Nakamura Japan	54	4.6k 1.3×	2.1k 0.8×	1.5k 0.7×	1.1k 0.5×	1.5k 1.4×	160	10.4k

Countries citing papers authored by Saburo Sone

Since Specialization

Citations

This map shows the geographic impact of Saburo Sone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saburo Sone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saburo Sone more than expected).

Fields of papers citing papers by Saburo Sone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saburo Sone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saburo Sone. The network helps show where Saburo Sone may publish in the future.

Co-authorship network of co-authors of Saburo Sone

This figure shows the co-authorship network connecting the top 25 collaborators of Saburo Sone. A scholar is included among the top collaborators of Saburo Sone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saburo Sone. Saburo Sone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Wei, Qi Li, Shinji Takeuchi, et al.. (2012). Met Kinase Inhibitor E7050 Reverses Three Different Mechanisms of Hepatocyte Growth Factor–Induced Tyrosine Kinase Inhibitor Resistance in EGFR Mutant Lung Cancer. Clinical Cancer Research. 18(6). 1663–1671. 76 indexed citations

Kuramoto, Takuya, Hisatsugu Goto, Atsushi Mitsuhashi, et al.. (2012). Dll4-Fc, an Inhibitor of Dll4-Notch Signaling, Suppresses Liver Metastasis of Small Cell Lung Cancer Cells through the Downregulation of the NF-κB Activity. Molecular Cancer Therapeutics. 11(12). 2578–2587. 41 indexed citations

Donev, Ivan, Wei Wang, Tadaaki Yamada, et al.. (2011). Transient PI3K Inhibition Induces Apoptosis and Overcomes HGF-Mediated Resistance to EGFR-TKIs in EGFR Mutant Lung Cancer. Clinical Cancer Research. 17(8). 2260–2269. 93 indexed citations

Ogino, Hirokazu, Masaki Hanibuchi, Soji Kakiuchi, et al.. (2011). E7080 Suppresses Hematogenous Multiple Organ Metastases of Lung Cancer Cells with Nonmutated Epidermal Growth Factor Receptor. Molecular Cancer Therapeutics. 10(7). 1218–1228. 16 indexed citations

Takahashi, Akiko, Noriko Motoi, Shin Yoshimoto, et al.. (2010). Intrinsic Cooperation between p16INK4a and p21Waf1/Cip1 in the Onset of Cellular Senescence and Tumor Suppression In vivo. Cancer Research. 70(22). 9381–9390. 94 indexed citations

Yamada, Tadaaki, Kunio Matsumoto, Wei Wang, et al.. (2009). Hepatocyte Growth Factor Reduces Susceptibility to an Irreversible Epidermal Growth Factor Receptor Inhibitor in EGFR -T790M Mutant Lung Cancer. Clinical Cancer Research. 16(1). 174–183. 85 indexed citations

Wang, Wei, Qi Li, Tadaaki Yamada, et al.. (2009). Crosstalk to Stromal Fibroblasts Induces Resistance of Lung Cancer to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. Clinical Cancer Research. 15(21). 6630–6638. 231 indexed citations

Ogino, Hirokazu, Seiji Yano, Soji Kakiuchi, et al.. (2009). Novel dual targeting strategy with vandetanib induces tumor cell apoptosis and inhibits angiogenesis in malignant pleural mesothelioma cells expressing RET oncogenic rearrangement. Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University). 17 indexed citations

Yano, Seiji, Wei Wang, Qi Li, et al.. (2008). Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations. Cancer Research. 68(22). 9479–9487. 513 indexed citations breakdown →

10.

Hanibuchi, Masaki, et al.. (2007). [Differences in the therapeutic strategies for lung cancer between Europe/United States and Japan].. PubMed. 34(5). 705–8. 1 indexed citations

11.

Takahashi, Koji, Chiyuki Furukawa, Atsushi Takano, et al.. (2006). The Neuromedin U-Growth Hormone Secretagogue Receptor 1b/Neurotensin Receptor 1 Oncogenic Signaling Pathway as a Therapeutic Target for Lung Cancer. Cancer Research. 66(19). 9408–9419. 112 indexed citations

12.

Muguruma, Hiroaki, Seiji Yano, Soji Kakiuchi, et al.. (2005). Reveromycin A Inhibits Osteolytic Bone Metastasis of Small-Cell Lung Cancer Cells, SBC-5, through an Antiosteoclastic Activity. Clinical Cancer Research. 11(24). 8822–8828. 39 indexed citations

13.

Furukawa, Chiyuki, Yataro Daigo, Nobuhisa Ishikawa, et al.. (2005). Plakophilin 3 Oncogene as Prognostic Marker and Therapeutic Target for Lung Cancer. Cancer Research. 65(16). 7102–7110. 108 indexed citations

14.

Aono, Yoshinori, Yasuhiko Nishioka, Mami Inayama, et al.. (2005). Imatinib as a Novel Antifibrotic Agent in Bleomycin-induced Pulmonary Fibrosis in Mice. American Journal of Respiratory and Critical Care Medicine. 171(11). 1279–1285. 196 indexed citations

15.

Goto, Hisatsugu, Seiji Yano, Helong Zhang, et al.. (2002). Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice.. PubMed. 62(13). 3711–5. 72 indexed citations

16.

Torisu, Hitoe, Mayumi Ono, Hiromaro Kiryu, et al.. (2000). Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: Possible involvement of TNFα and IL-1α. International Journal of Cancer. 85(2). 182–188. 225 indexed citations

17.

Tani, Kenji, Fumitaka Ogushi, Lüping Huang, et al.. (2000). CD13/aminopeptidase N, a Novel Chemoattractant for T Lymphocytes in Pulmonary Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 161(5). 1636–1642. 42 indexed citations

18.

Shimizu, Eiji, et al.. (1996). Detection of auto‐antibodies against L‐myc oncogene products in sera from lung cancer patients. International Journal of Cancer. 69(4). 283–289. 2 indexed citations

19.

Sone, Saburo, et al.. (1977). Phycomycosis in Intestine Complicated wite Acute Leukemia:Report of a Case. 18(2). 87–91. 1 indexed citations

20.

Sone, Saburo, et al.. (1977). Rebound phenomenon of phytohemagglutinin skin reactivity in leukemia and malignant lymphoma after chemotherapy.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 68(4). 483–90. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact